Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
JUBLPHARMA Stock Analysis
Views
Red Flags
Positive
Strong price momentum
Analysts have been raising forward EPS estimates
Moderate operating margin but improving trend
Low Debt to Equity, not much change from last year
Company's earnings are of high quality
Consistently pays dividend
Negative
Expensive and at a premium to industry median P/E
Low and declining ROE
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
Moderate revenue growth and in line with median growth of industry
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
JUBLPHARMA Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
JUBLPHARMA Bulk, Block & Insider Trades
JUBLPHARMA Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Bonus
Stock split
Others
Bonus(3 new shares for 5 existing shares)Bonus issue of 8798139 securities Ex-date: 12th Mar 2004 Announced on: 12th Mar 2004
Stock split(1 : 5)Nominal value change from Rs. 5 to Rs. 1 Ex-date: 17th Mar 2006 Announced on: 7th Mar 2006
Stock split(1 : 2) Ex-date: 12th Nov 2002 Announced on: 10th Oct 2002
Demerger (DEM)Demerger of Jubilant Ingrevia Limited (Resulting company) from Jubilant Life Sciences Limited. Share holders will be entitled for allotment of one equity share of Jubilant Ingrevia Limited for every one equity share held in Jubilant Life Sciences Limited. Ex-date: 4th Feb 2021 Announced on: 7th Jan 2020
Demerger (DEM)BOD 08 July 2010. Demerger of Agri and Performance Polymer DivisionsJubilant Industries will issue 1 equity share of INR 10 for every 20 equity shares of INR 1 each held by a Shareholder in Jubilant Organosys as on the Demerger Record Date. Ex-date: 25th Nov 2010 Announced on: 8th Jul 2010
MergerIn terms of scheme of amalgamation the subsidiaries Vam Industries Ltd. (VIL) and Vam Leasing Ltd. (VLL) have been amalgamated with the company with effect from 1 April 2002 at their fair value. Accordingly the undertaking and business of both VIL and VLL has been transferred to and vested with the ... Read More Ex-date: 31st Mar 2003 Announced on: 31st Mar 2003
Company Profile
Jubilant Pharmova Limited is an India-based integrated pharmaceutical company. The Company’s segments include Radiopharma, Allergy Immunotherapy, Contract Development and Manufacturing Organisation-Sterile Injectables, Generics, Contract Research, Development and Manufacturing Organisation, Propriet... Read More
Key personnel
Mr. Hari Shanker BhartiaD
Non-Executive Co-Chairman of the Board
Mr. Shyam Sunder BhartiaD
Non-Executive Chairman of the Board
Mr. Arun Kumar Sharma
Chief Financial Officer
Mr. Naresh Kapoor
Compliance Officer, Company Secretary
Mr. Arjun Shanker BhartiaD
Joint Managing Director, Executive Director
Shri. Priyavrat BhartiaD
Managing Director, Executive Director
Mr. Shirish Gundopant BelapureD
Non-Executive Independent Director
Dr. Harsh MahajanD
Non-Executive Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Jubilant Pharmova Ltd.?
The current share price of Jubilant Pharmova Ltd. is ₹ 1,063.33 as of 09 Jan 2026.
What is the PE ratio of Jubilant Pharmova Ltd.?
The Price-to-Earnings (PE) ratio of Jubilant Pharmova Ltd. is 35.29 as of the latest financial data.
What is the ROE and ROCE of Jubilant Pharmova Ltd.?
Jubilant Pharmova Ltd. has a Return on Equity (ROE) of 7.62% and a Return on Capital Employed (ROCE) of 9.05% as per the latest financial reports.
What is the market cap of Jubilant Pharmova Ltd.?
The market capitalization of Jubilant Pharmova Ltd. stands at ₹ 16,842.80 Cr.
What is the dividend yield of Jubilant Pharmova Ltd.?
The dividend yield of Jubilant Pharmova Ltd. is 0.47% based on the current market price.
What is the RSI of Jubilant Pharmova Ltd.?
The Relative Strength Index (RSI) of Jubilant Pharmova Ltd. is 46.86.
What is the FII and DII holding in Jubilant Pharmova Ltd.?
Foreign Institutional Investors (FII) hold 16.56% and Domestic Institutional Investors (DII) hold 8.26% of Jubilant Pharmova Ltd. shares.
What sector does Jubilant Pharmova Ltd. belong to?
Jubilant Pharmova Ltd. operates in the Healthcare sector.
What is the beta of Jubilant Pharmova Ltd. stock?
The beta of Jubilant Pharmova Ltd. stock is 0.88, indicating its volatility relative to the broader market.
